Dajas F, Barbeito L, Martinez-Pesquera G, Lista A, Puppo D, Puppo-Touriz H
Neuropsychobiology. 1983;10(2-3):70-4. doi: 10.1159/000117988.
Plasma noradrenaline was assayed in schizophrenics selected according to research diagnostic criteria. Clinical symptomatology was simultaneously rated according to the comprehensive psychopathological rating scale. Global psychopathology, positive (delusional, hallucinatory), negative (autistic), paranoid and hallucinatory symptomatology were separately rated. Noradrenaline was significantly higher in schizophrenics than in a normal control group. A correlation analysis was applied to both psychopathology and plasmatic noradrenaline levels. Noradrenaline was significantly correlated (p less than 0.05 to p less than 0.02) with global psychopathology, positive symptoms and paranoid symptomatology. No correlation was demonstrated between plasma noradrenaline and negative and hallucinatory symptomatology. Plasma noradrenaline is proposed to be related to a high level of sympathetic general activity in schizophrenics, specially associated with paranoid symptomatology.
根据研究诊断标准选取精神分裂症患者测定其血浆去甲肾上腺素水平。同时依据综合精神病理学评定量表对临床症状进行评分。对整体精神病理学、阳性症状(妄想、幻觉)、阴性症状(孤僻)、偏执症状及幻觉症状分别进行评分。精神分裂症患者的去甲肾上腺素水平显著高于正常对照组。对精神病理学和血浆去甲肾上腺素水平进行相关性分析。去甲肾上腺素与整体精神病理学、阳性症状及偏执症状显著相关(p值小于0.05至小于0.02)。血浆去甲肾上腺素与阴性症状及幻觉症状之间未显示出相关性。血浆去甲肾上腺素被认为与精神分裂症患者较高水平的交感神经总体活动有关,尤其与偏执症状相关。